FOXP3: Of mice and men

Annual Review of Immunology

Volumn 24, Issue , 2006, Pages 209-226

  Ziegler, Steven F ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Forkhead; Regulatory T cell; Transcription factor

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; EFFECTOR CELL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE FUNCTION; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; REVIEW; THYMUS;

ANIMALS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; MICE; MUTATION; PROTEIN ISOFORMS; SPECIES SPECIFICITY;

EID: 33646168597     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.24.021605.090547     Document Type: Review

References (96)

1. + regulatory T cells. Semin. Immunol. 16:89-98
2. + regulatory T cells. Trends Immunol. 25:374-80
3. + suppressor T cells: more questions than answers. Nat. Rev. Immunol 2:389-400
4. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6:345-52
5. Fontenot JD, Rudensky AY. 2005. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6:331-37
6. Godfrey V, Rouse BT, Wilkinson JE. 1994. Transplantation of T cell-mediated lymphoreticular disease from the scurfy (sf) mouse. Am. J. Pathol. 145:281-86
7. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, et al. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985-88
8. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-47
9. Kanangat S, Blair P, Reddy R, Deheshia M, Godfrey V, et al. 1996. Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur. J. Immunol. 26:161-65
10. Clark LB, Appleby MW, Brunkow ME, Wilkinson JE, Ziegler SF, Ramsdell F. 1999. Cellular and molecular characterization of the scurfy mouse mutant. J. Immunol. 162:2546-54
11. Bettelli E, Dastrange M, Oukka M. 2005. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102:5138-43
12. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, et al. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68-73
13. Khattri R, Kasprowicz DJ, Cox T, Yasayko S-A, Ziegler SF, Ramsdell F. 2001. The amount of scurfin protein determines peripheral T cell number and responsiveness. J. Immunol. 167:6312-20
14. 13a. Kasprowicz DJ, Droin N, Ramsdell F, Green DR, Ziegler SF. 2006. Elevated FoxP3 expression leads to activation-induced cell death, while effector cell differentiation correlates with loss of FoxP3 expression. Eur J. Immunol. In press
15. + T cell effector function. J. Immunol. 171:1216-23
16. + regulatory T cells. Nat. Immunol. 4:330-36
17. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor FoxP3. Science 299:1057-61
18. + T regulatory cells. Nat. Immunol. 4:337-42
19. - T cells. J. Clin. Invest. 112:1437-43
20. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-64
21. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1212-18
22. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329-41
23. Wan YY, Flavell RA. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102:5126-31
24. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169:4712-16
25. + T cells and the control of autoimmune disease. Curr. Opin. Immunol. 16:695-701
26. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, et al. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199:1455-65
27. - T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 79:1310-16
28. Jaeckel E, von Boehmer H, Manns MP. 2005. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 54:306-10
29. + T-cells expressing Foxp3. Diabetes 54:1040-47
30. Tai X, Cowan M, Feigenbaum L, Singer A. 2005. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6:152-62
31. + regulatory T cells. J. Immunol. 171:3348-52
32. + regulatory T cells. Novartis Found. Symp. 252:55-63
33. + regulatory T cell activity: it takes (IL-)two to tango. Eur. J. Immunol. 35:1336-41
34. Nelson BH. 2004. IL-2, regulatory T cells, and tolerance. J. Immunol. 172:3983-88
35. Malek TR, Bayer AL. 2004. Tolerance, no immunity, critically depends on IL-2. Nat. Rev. Immunol. 4:665-74
36. Nelson BH. 2002. Interleukin-2 signaling and the maintenance of self-tolerance. Curr. Dir. Autoimmun. 5:92-112
37. Schimpl A, Berberich I, Kneitz B, Kramer S, Santner-Nanan B, et al. 2002. IL-2 and autoimmune disease. Cytokine Growth Factor Rev. 13:369-78
38. Snow JW, Abraham N, Ma MC, Herndier BG, Pastuszak AW, Goldsmith MA. 2003. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J. Immunol. 171:5042-50
39. + memory T cells. J. Immunol. 171:5853-64
40. Malek TR, Porter BO, Codias EK, Scibelli P, Yu A. 2000. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol. 164:2905-14
41. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice: implications for the nonredundant function of IL-2. Immunity 17:167-78
42. + T regulatory cell development during the neonatal period. J. Exp. Med. 201:769-77
43. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201:723-35
44. + regulatory T cells. J. Exp. Med. 201:1061-67
45. + regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA 101:4572-77
46. + regulatory T cells by TGF-β induction of transcription factor FoxP3. J. Exp. Med. 198:1875-86
47. - T cells through FoxP3 induction and down-regulation of Smad7. J. Immunol. 172:5149-53
48. - precursors. Am. J. Transplant. 4:1614-27
49. Nelson BH, Martyak TP, Thompson LJ, Moon JJ, Wang T. 2003. Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-β signaling. J. Immunol. 170:5563-70
50. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196:237-46
51. + T-cell pool and the expression of Foxp3 in vivo. Int. Immunol. 16:1241-49
52. + T cells. J. Immunol. 173:6526-31
53. + regulatory T cells. J. Exp. Med. 201:737-46
54. Kaestner K, Knöchel W, Martinez D. 2000. Unified nomenclature for the winged-helix/forkhead transcription factors. Genes Dev. 14:142-46
55. Kaufmann E, Knöchel W. 1996. Five years on the wings of fork head. Mech. Dev. 57:3-20
56. Kaufmann E, Müller D, Knöchel W. 1995. DNA recognition site analysis of Xenopus winged helix proteins. J. Mol. Biol. 248:239-54
57. Li C, Tucker PW. 1993. DNA-binding properties and secondary structural model of the hepatocyte nuclear factor 3/fork head domain. Proc. Natl. Acad. Sci. USA 90:11583-87
58. Schubert LA, Jeffery EW, Zhang Y, Ramsdell F, Ziegler SF. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276:37672-79
59. Li S, Weidenfeld J, Morrisey EE. 2004. Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol. Cell. Biol. 24:809-22
60. Wang B, Lin D, Li C, Tucker PW. 2003. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J. Biol. Chem. 278:24259-68
61. Powell BR, Buist N, Stenzel P. 1982. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr. 100:731-37
62. Bennett CL, Ochs HD. 2001. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr. Opin. Pediatr. 13:533-38
63. Gambineri E, Torgerson TR, Ochs HD. 2003. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T cell homeostasis. Curr. Opin. Rheumatol. 15:430-35
64. Torgerson TR, Ochs HD. 2002. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a model of immune dysregulation. Curr. Opin. Allergy Clin. Immunol. 2:481-87
65. Nieves DS, Phipps RP, Pollock SJ, Ochs HD, Zhu Q, et al. 2004. Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch. Dermatol. 140:466-72
66. Ochs HD, Ziegler SF, Torgerson TR. 2005. FOXP3 acts as a rheostat of the immune response. Immunol. Rev. 203:156-64
67. Owen CJ, Jennings CE, Imrie H, Lachaux A, Bridges NA, et al. 2003. Mutational analysis of the FOXP 3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. J. Clin. Endocrinol. Metab. 88:6034-39
68. Kobayashi I, Shiari R, Yamada M, Kawamura N, Okano M, et al. 2001. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J. Med. Genet. 38:874-76
69. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova J-L, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18-20
70. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PF, et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutation of FOXP3. Nat. Genet. 27:20-21
71. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, et al. 2000. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106:R75-81
72. Wilden RS, Smyk-Pearson S, Filipovich AH. 2002. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy X linked (IPEX) syndrome. J. Med. Genet. 39:537-15
73. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285-94
74. + T cells with regulatory properties from human blood. J. Exp. Med. 193:1303-10
75. high regulatory cells in human peripheral blood. J. Immunol. 167:1245-53
76. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295-302
77. + T regulatory cells. J. Clin. Invest. In press
78. + T regulatory cells in humans. Hum. Immunol. 66:13-20
79. + regulatory T cells at the single-cell level. Eur. J. Immunol. 18:1681-91
80. + T-cells. Blood. In press
81. + regulatory T cells. Int. Immunol. 16:1643-56
82. Oswald-Richter K, Grill SM, Shariat N, Leelawong M, Sundrud MS, et al. 2004. HIV infection of naturally occurring and genetically reprogrammed human regulatory T cells. PLoS Biol. 2:955-66
83. +. Proc. Natl. Acad. Sci. USA 102:4103-8
84. Bluestone JA, Abbas AK. 2003. Natural versus adapted regulatory T cells. Nat. Rev. Immunol. 3:253-57
85. Moore KJ, de Waal MR, Coffman R, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765
86. high, proliferating subset. Int. Immunol. 13:799-806
87. Buckner JH, Holzer U, Novak EJ, Reijonen H, Kwok WW, Nepom GT. 2002. Defining antigen-specific responses with human MHC class II tetramers. J. Allergy. Clin. Immunol. 110:199-208
88. + T cells. Arthritis Rheum. 46:5-12
89. Loser K, Hansen W, Apelt J, Balkow S, Buer J, Beissert S. 2005. In vitro-generated regulatory T cells induced by FoxP3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther. In press
90. Mehling A, Loser K, Varga G, Metze D, Luger TA, et al. 2001. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194:615-28
91. Cofffer PJ, Burgering BM. 2004. Forkhead box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4:889-99
92. Pignata C, Gaetaniello L, Masci AM, Frank J, Christiano A, et al. 2001. Human equivalent of the mouse Nude/SCID phenotype: long-term evaluation of immunologic reconstitution after bone marrow transplantation. Blood 97:880-85
93. Nehls M, Pfeifer D, Schorpp M, Hedrich H, Boehm T. 1994. New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature 372:103-7
94. Lin L, Spoor MS, Gerth AJ, Body SL, Peng SL. 2004. Modulation of Th1 activation and inflammation by the NF-κB repressor Foxj1. Science 303:1017-20
95. Lin L, Hron JD, Peng SL. 2004. Regulation of NF-κB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21:203-13
96. Burgering BM, Kops GJ. 2002. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27:352-60